Transplantation.
- 16 May 1990
- journal article
- Vol. 263 (19) , 2686-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Early trials with FK 506 as primary treatment in liver transplantation.1990
- Second International Workshop on FK 506. A potential breakthrough in immunosuppression: clinical implications. October 31, 1989, Barcelona, Spain. Proceedings.1990
- AUGMENTATION OF RAT LIVER REGENERATION BY FK 506 COMPARED WITH CYCLOSPORINThe Lancet, 1989
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- ANTI-INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODY IN THE TREATMENT OF ONGOING ACUTE REJECTION EPISODES OF HUMAN KIDNEY GRAFT-A PILOT STUDYTransplantation, 1989
- The ninaA gene required for visual transduction in Drosophila encodes a homologue of cyclosporin A-binding proteinNature, 1989
- Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilinNature, 1989
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987
- Isolation and amino acid sequence of cyclophilin.Journal of Biological Chemistry, 1986
- The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomeraseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985